Early day motion tabled by primary sponsor Sandra Gidley (Liberal Democrat), on Tuesday, 13 May 2003, in the House of Commons. It is signed by 41 members in total.
ANTI-DEPRESSANT DRUG SEROXAT
That this House calls for the anti-depressant drug Seroxat to be withdrawn from use for new prescribing pending an urgent, fully independent review of its and other SSRI anti-depressants' safety, because of the extensive evidence of severe withdrawal reactions and an increased risk of suicide associated with it; and calls on the Medicines and Healthcare Products Regulation Agency in conducting the review to include people with experience of using Seroxat and to make full use of the consumer-based evidence and research available, such as that conducted by Panorama and Mind.
Secondary information
- Type
- Early day motion
- Reference
- 1203
- Session
- 2002-03
- Subjects
- Depressive illnesses Drugs Safety Side effects Antidepressants
- Link
- View this Early day motion on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-10-01 15:27:13 +0100
- URI
- http://data.parliament.uk/edms/22807
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/22807
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/22807